Association between phosphate removal and markers of bone turnover in haemodialysis patients
Author(s) -
Marta Albalate,
Concepción de la Piedra,
Cristina Boté i Fernández,
M. Lefort,
Henar Santana,
Paloma Hernando,
Jesús Hernández Hernández,
Carlos Caramelo
Publication year - 2006
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfl034
Subject(s) - phosphate , osteoprotegerin , medicine , endocrinology , rankl , bicarbonate , bone remodeling , alkaline phosphatase , hyperparathyroidism , secondary hyperparathyroidism , vitamin d and neurology , acid phosphatase , population , parathyroid hormone , fibroblast growth factor 23 , calcium , chemistry , receptor , activator (genetics) , biochemistry , enzyme , environmental health
As the main mineral reservoir, bone acts as a calcium (Ca) and phosphate buffering system. Accordingly, phosphate removal by haemodialysis (HD) might be theoretically influenced by bone turnover, as well as by the interaction of regulatory molecules, such as PTH and osteoprotegerin (OPG). The present study investigated the relationship between these variables and phosphate removal by HD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom